Akso Health Group ADR (AHG) - Net Assets

Latest as of September 2025: $198.31 Million USD

Based on the latest financial reports, Akso Health Group ADR (AHG) has net assets worth $198.31 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($212.04 Million) and total liabilities ($13.73 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset allocation strategy of Akso Health Group ADR to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets $198.31 Million
% of Total Assets 93.52%
Annual Growth Rate 50.45%
5-Year Change 1053.06%
10-Year Change 1321.29%
Growth Volatility 450.42

Akso Health Group ADR - Net Assets Trend (2015–2025)

This chart illustrates how Akso Health Group ADR's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Akso Health Group ADR market capitalisation.

Annual Net Assets for Akso Health Group ADR (2015–2025)

The table below shows the annual net assets of Akso Health Group ADR from 2015 to 2025. Also explore AHG net assets growth trend to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-03-31 $199.15 Million +43.87%
2024-03-31 $138.42 Million +1465.97%
2023-03-31 $8.84 Million -28.05%
2022-03-31 $12.29 Million -28.87%
2021-03-31 $17.27 Million -64.09%
2020-03-31 $48.10 Million -61.98%
2019-03-31 $126.50 Million -9.67%
2018-03-31 $140.04 Million +495.82%
2017-03-31 $23.50 Million +67.74%
2016-03-31 $14.01 Million +318.22%
2015-03-31 $3.35 Million --

Equity Component Analysis

This analysis shows how different components contribute to Akso Health Group ADR's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 19855358100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Common Stock $165.68K 0.08%
Other Comprehensive Income $-3.77 Million -1.89%
Other Components $401.63 Million 201.70%
Total Equity $199.12 Million 100.00%

Akso Health Group ADR Competitors by Market Cap

The table below lists competitors of Akso Health Group ADR ranked by their market capitalization.

Company Market Cap
Wetown Electric Group Co Ltd
SHG:688226
$807.41 Million
RHI MAGNESITA INDIA LIMITED
NSE:RHIM
$807.54 Million
Wuhan Xianglong Power Industry Co Ltd
SHG:600769
$807.70 Million
Shanghai Hajime Advanced Material Technology Co. Ltd.
SHE:301000
$807.91 Million
JC Finance & Tax Interconnect Holdings Ltd
SHE:002530
$807.27 Million
Zhejiang Meili High Technology Co Ltd
SHE:300611
$806.76 Million
Santacruz Silver Mining Ltd.
V:SCZ
$806.54 Million
SKF India Limited
NSE:SKFINDIA
$806.52 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Akso Health Group ADR's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 138,367,384 to 199,119,145, a change of 60,751,761 (43.9%).
  • Net loss of 134,977,369 reduced equity.
  • New share issuances of 195,884,024 increased equity.
  • Other comprehensive income increased equity by 315,213.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-134.98 Million -67.79%
Share Issuances $195.88 Million +98.38%
Other Comprehensive Income $315.21K +0.16%
Other Changes $-470.11K -0.24%
Total Change $- 43.91%

Book Value vs Market Value Analysis

This analysis compares Akso Health Group ADR's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.04x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 3.37x to 3.04x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-03-31 $0.63 $2.12 x
2016-03-31 $2.63 $2.12 x
2017-03-31 $4.41 $2.12 x
2018-03-31 $26.45 $2.12 x
2019-03-31 $21.52 $2.12 x
2020-03-31 $8.88 $2.12 x
2021-03-31 $3.18 $2.12 x
2022-03-31 $0.62 $2.12 x
2023-03-31 $1.14 $2.12 x
2024-03-31 $5.81 $2.12 x
2025-03-31 $0.70 $2.12 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Akso Health Group ADR utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -67.79%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -913.38%
  • • Asset Turnover: 0.07x
  • • Equity Multiplier: 1.08x
  • Recent ROE (-67.79%) is below the historical average (-43.15%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -10.45% -7.54% 0.63x 2.21x $-685.21K
2016 25.25% 29.75% 0.53x 1.60x $2.14 Million
2017 36.47% 37.39% 0.81x 1.21x $6.22 Million
2018 46.76% 61.05% 0.65x 1.17x $51.48 Million
2019 4.37% 9.02% 0.35x 1.37x $-7.12 Million
2020 -148.02% -1029.70% 0.09x 1.67x $-76.01 Million
2021 -201.64% -1984.52% 0.06x 1.83x $-36.55 Million
2022 -137.17% -266.99% 0.12x 4.13x $-18.08 Million
2023 -15.59% -10.32% 0.64x 2.34x $-2.23 Million
2024 -6.84% -391.78% 0.02x 1.03x $-23.30 Million
2025 -67.79% -913.38% 0.07x 1.08x $-154.89 Million

Industry Comparison

This section compares Akso Health Group ADR's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $1,128,944,986
  • Average return on equity (ROE) among peers: 9.40%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Akso Health Group ADR (AHG) $198.31 Million -10.45% 0.07x $807.33 Million
Accendra Health Inc (ACH) $314.40 Million 8.91% 1.75x $84.85 Million
Cardinal Health Inc (CAH) $1.79 Billion 34.06% 23.78x $43.01 Billion
Cencora Inc. (COR) $3.32 Billion 10.40% 2.38x $50.53 Billion
Cosmos Health Inc. (COSM) $-6.46 Million 0.00% 0.00x $14.53 Million
EDAP TMS SA (EDAP) $34.78 Million 33.77% 0.45x $154.80 Million
Empro Group Inc. Ordinary shares (EMPG) $741.21K -42.90% 4.10x $143.05 Million
EDAP TMS S.A. (FOCL) $31.46 Million -2.44% 0.79x $153.11 Million
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) $4.25 Million 31.26% 1.04x $4.78 Million
Henry Schein Inc (HSIC) $4.67 Billion 11.52% 0.84x $7.86 Billion

About Akso Health Group ADR

NASDAQ:AHG USA Medical Distribution
Market Cap
$1.16 Billion
Market Cap Rank
#9860 Global
#2700 in USA
Share Price
$2.12
Change (1 day)
+7.07%
52-Week Range
$1.12 - $2.50
All Time High
$40.16
About

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more